Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
Pfizer(PFE) stock is priced at $27.03, giving the company a market capitalization of 153.7B. It carries a P/E multiple of 19.94 and pays a dividend yield of 6.4%.
As of 2026-03-30, Pfizer(PFE) stock has fluctuated between $27.02 and $27.77. The current price stands at $27.03, placing the stock +0.0% above today's low and -2.7% off the high.
Pfizer(PFE) shares are trading with a volume of 29.12M, against a daily average of 42.5M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
In the last year, Pfizer(PFE) shares hit a 52-week high of $27.94 and a 52-week low of $20.92.
PFE News
Key Points Pfizer has a proven track record of success in the pharmaceutical sector. Management has shown, once again, that it can pivot quickly when needed....
Pfizer (NYSE:PFE) reported positive Phase 2 results for atirmociclib in metastatic breast cancer. The company announced favorable Phase 3 TALAPRO-3 data for TA...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 30% Off TipRanks Premium Unlock hedge fund-lev...
Analyst ratings
55%
of 29 ratingsMore PFE News
Option traders moderately bearish in Pfizer (PFE), with shares down 18c near $27.39. Options volume roughly in line with average with 52k contracts traded and c...
Earlier this month, Pfizer and Valneva reported that their Phase 3 VALOR trial of the investigational 6‑valent Lyme disease vaccine showed more than 70% efficac...
Income Investors Face a Hard Truth About Pfizer’s Payout Safety By Trey Thoelcke Published Mar 26, 7:55AM EDT Quick Read Pfizer (PFE) paid $9.771B in dividend...
Key Points Pfizer's recent phase 2 win was encouraging, but not yet a slam dunk. The company could make significant clinical and regulatory progress in the ne...
This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In By Joey Frenette Published Mar 25, 12:23PM EDT Quick Read Pfizer (P...
Bristol Myers Squibb BMY recently won FDA and European Commission (EC) approvals for the label expansion of its blockbuster immuno-oncology (IO) drug Opdivo. T...
Tuesday’s total option volume of 56.5 million contracts resulted in net open interest growth of 7.38 million calls and 5.85 million puts. fuboTV (FUBO), NVIDIA...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.